XJPX
4403
Market cap3.88bUSD
Jul 10, Last price
2,739.00JPY
1D
-1.56%
1Q
-15.49%
Jan 2017
265.20%
Name
NOF Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1937 and headquartered in Tokyo, Japan, NOF Corporation is a chemical manufacturing enterprise with diversified operations across several key sectors. The company primarily conducts business through its Functional Chemicals, Life Science, and Explosive & Propulsion divisions. The Functional Chemicals segment is responsible for producing a wide array of specialized substances, including fatty acids and their derivatives, various surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, advanced functional polymers and films, petrochemical products, electronic materials, and sophisticated corrosion prevention agents. Within its Life Science division, NOF offers products such as edible oils, nutritional supplements (functional foods), activated polyethylene glycol (PEG), unique functional lipids, pharmaceutical-grade surfactants, biocompatible materials, ingredients derived from plants, and MPC polymer/monomer. The Explosive & Propulsion segment focuses on manufacturing industrial explosives, solid and liquid propellants for firearms and rockets, pyrotechnic devices, complete guided missile assemblies, anti-freezing compounds, and specialized indicators for temperature and sterilization. Beyond its core chemical activities, the corporation also extends its business ventures into logistics, operates an insurance agency, and is involved in real estate.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||